Ontology highlight
ABSTRACT:
SUBMITTER: Wan A
PROVIDER: S-EPMC4647364 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
Acta crystallographica. Section E, Crystallographic communications 20150912 Pt 10
The title compounds, C26H28N2, (I), and C28H32N2, (II), were designed based on the structure of the potent α9α10 nicotinic acetyl-choline receptor antagonist ZZ161C {1,1'-[[1,1'-biphen-yl]-4,4'-diylbis(prop-2-yne-3,1-di-yl)]bis-(3,4-di-methyl-pyridin-1-ium) bromide}. In order to improve the druglikeness properties of ZZ161C for potential oral administration, the title compounds (I) and (II) were prepared by coupling 4,4'-bis-(3-bromo-prop-1-yn-1-yl)-1,1'-biphenyl with pyrrol-idine, (I), and (S)- ...[more]